Poland· PL-100048334
Norprolac
A quinagolide product containing quinagolidum, registered in Poland by Ferring GmbH. The same ATC class is registered in 9 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Quinagolide is registered in 9 of 19 countries.
Countries holding a registration under ATC G02CB04 (quinagolide), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Quinagolide · ATC G02CB04
9 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Quinagolidum
- Manufacturer
- Ferring GmbH
- Country
- Poland (PL)
- ATC code
- G02CB04
- ATC class
- Quinagolide
- Defined daily dose
- 75 mcg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990681112
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Quinagolide in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomNorprolac 75microgram tabletsDowelhurst Ltd
- SwedenNorprolac 75 mikrogram TablettOrifarm AB
- SwitzerlandNorprolac 75 ug, TablettenFerring AG
- CzechiaNORPROLACFerring-Léčiva, a.s., Jesenice u Prahy
- SpainNORPROLAC 75 microgramos COMPRIMIDOSFerring S.A.
- FinlandNorprolacFerring Lääkkeet Oy
- BelgiumNorprolac 150 µgFerring
- FranceNORPROLAC 150 microgrammes, compriméFERRING (FRANCE)
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Austria · Norprolac
- Czechia · Norprolac
- Germany · Norprolac
- France · Norprolac
- United Kingdom (Northern Ireland) · Norprolac, Quinagolide Aspire Pharma
- Greece · Norprolac
- Hungary · Norprolac
- Netherlands · Norprolac
- Slovakia · Norprolac
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/04350924-3540-49c1-828e-ab9a2b8df6a3 GET /v1/drugs/04350924-3540-49c1-828e-ab9a2b8df6a3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "75 mcg",
"packaging": "05909990681112 ¦ Rp ¦ 7214\n30 tabl.",
"substance": "Quinagolidum 75 mcg",
"common_name": "Quinagolidum",
"pl_product_id": "100048334",
"pozwolenie_nr": "06811",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about quinagolide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.